Anupam Rasayan India Limited

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange about intimation of ESG Rating, with Crisil ESG Ratings & Analytics Limited assigning a rating of 'Crisil ESG 62' and a Core ESG rating of 'Crisil Core ESG 63' (Strong).

Anupam Rasayan India Limited

Anupam Rasayan India Limited has confirmed that Regulation 74(5) of SEBI DP Regulations is not applicable for the quarter ended September 30, 2026, as the entire holding of the company's shares are in dematerialized form.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has submitted the Exchange a copy Srutinizer's report and e-voting results of 23rd Annual General Meeting held on September 30, 2026.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange about an update on the disclosure dated 28 September 2026 regarding the acquisition of equity shares of Bliss GVS Pharma Limited. The company has clarified certain typographical errors in the previous disclosure, stating that the acquisition of 5,09,84,595 equity shares of Bliss representing 47.95% has been consummated by the Acquirer and PAC on 28 September 2026.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has acquired 22,50,000 equity shares of Bliss GVS Pharma Limited through an on-market transaction, taking its total stake to 47.95% of Bliss's equity share capital.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has acquired a 48.2% controlling stake in Bliss GVS Pharma Limited for ₹299 per share, marking its third strategic inorganic transaction. The acquisition expands Anupam Rasayan's presence into finished dosage formulations and strengthens its manufacturing and process chemistry capabilities.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange about giving guarantees/indemnity/becoming a surety for third party. The company has executed debenture trust deed, deed of pledge, corporate guarantee, and call option agreement with Mates Visa Consultancy Private Limited and Purebliss Pharma Solutions Private Limited. The details of the agreements are as per Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has executed security documents, including a debenture trust deed, an unattested deed of pledge, a corporate guarantee, and a call option agreement. The documents are related to the issuance of up to INR 300 crore senior, secured, unrated, unlisted, redeemable, non-convertible debentures by Mates Visa Consultancy Private Limited (MVCPL) on a private placement basis.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange regarding allotment of 14,500 secured, rated, unlisted and redeemable non-convertible debentures to Aditya Birla Capital Limited, aggregating to INR 1,45,00,00,000, to be utilised for repayment of existing debt facilities and/or for investment in group companies and/or for general corporate purposes.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange about issuance of non-convertible debentures on a private placement basis, with proceeds proposed to be utilised for repayment of existing debt facilities and/or for investment in group companies and/or for general corporate purposes.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange regarding Outcome of Board Meeting held on September 19, 2026. The Board of Directors has approved the issuance of up to INR 1,60,00,00,000 (Indian Rupees One Hundred Sixty Crore Only) non-convertible debentures on a private placement basis. The proceeds from the issue are proposed to be utilised by the Company for repayment of existing debt facilities and/or for investment in group companies and/or for general corporate purposes.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange regarding Outcome of Board Meeting held on September 17, 2026, where the Board approved the execution of certain security documents for financing by its wholly-owned subsidiary, Mates Visa Consultancy Private Limited, and creation of pledge over equity shares of Mates and Purebliss.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange about the acquisition of equity shares in Tanfac Industries Limited pursuant to a preferential issue. The company accepted, executed, and delivered the acceptance form to Tanfac, and the details were provided in an earlier intimation.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange about the Newspaper Advertisement regarding 23rd Annual General Meeting of the members of the Company.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange regarding Notice of 23rd Annual General Meeting of the members of the Company to be held on September 30, 2026.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange about acquisition of equity shares in Tanfac Industries Limited pursuant to a preferential issue. The Board has approved the acquisition of 2,60,065 equity shares of Tanfac at the issue price of Rs. 2,341 each, on a preferential issue basis for an aggregate consideration of Rs. 60,88,12,165.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has appointed Ms. Hetvi Vyas as Deputy Chief Financial Officer and Key Managerial Officer, effective September 08, 2026.

Anupam Rasayan India Limited

Anupam Rasayan India Limited has informed the Exchange that the Record Date for the purpose of Dividend is September 18, 2026.